Belgravia Hartford Capital Inc buy krebskrebs
Start price
28.04.20
/
50%
€0.005
Target price
04.11.21
€0.80
Performance (%)
1850.00%
End price
05.11.21
€0.098
Summary
This prediction ended on 05.11.21 with a price of €0.098. With a performance of 1850.00% the BUY prediction by krebskrebs was a big success. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Belgravia Hartford Capital Inc | - | - | - | - |
| iShares Core DAX® | 0.597% | 3.083% | 16.090% | 16.439% |
| iShares Nasdaq 100 | 0.899% | 5.338% | 29.239% | 56.431% |
| iShares Nikkei 225® | 1.775% | -1.206% | 6.823% | 4.774% |
| iShares S&P 500 | 0.990% | 3.500% | 24.956% | 47.182% |
Comments by krebskrebs for this prediction
In the thread Belgravia Hartford Capital Inc diskutieren
Buy mit Kursziel 0,08
In the thread Trading Belgravia Hartford Capital Inc
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten